Loading…

Thermal Stability: A Means to Assure Tertiary Structure in Therapeutic Proteins

To be both safe and effective, a therapeutic product must have the correct chemical structure and be free of harmful contaminants. Structure in protein therapeutic products, however, implies not only the correct sequence of amino acids (primary structure) but also the proper folding of that amino ac...

Full description

Saved in:
Bibliographic Details
Published in:Biologicals 2002-09, Vol.30 (3), p.175-185
Main Authors: Cauchy, Mike, D'aoust, Sophie, Dawson, Brian, Rode, Harold, Hefford, Mary Alice
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c371t-bbebe611caca6df6f4547fb0a5544765dd71ea0dedfd3cbe83a37e549b5cbd9b3
cites cdi_FETCH-LOGICAL-c371t-bbebe611caca6df6f4547fb0a5544765dd71ea0dedfd3cbe83a37e549b5cbd9b3
container_end_page 185
container_issue 3
container_start_page 175
container_title Biologicals
container_volume 30
creator Cauchy, Mike
D'aoust, Sophie
Dawson, Brian
Rode, Harold
Hefford, Mary Alice
description To be both safe and effective, a therapeutic product must have the correct chemical structure and be free of harmful contaminants. Structure in protein therapeutic products, however, implies not only the correct sequence of amino acids (primary structure) but also the proper folding of that amino acid chain in three-dimensional space (tertiary structure). This work is part of a general strategy to develop a battery of physico-chemical methods that could give assurances of structure (and hence function) in formulated therapeutic proteins in the absence of in vivo data. It focuses on recombinant human growth hormone (rhGH), a well-characterized therapeutic protein, and examines the utility of thermodynamic parameters in assessing its tertiary structure. Resistance of solutions of formulated rhGH to thermal denaturation was followed using Fourier Transform Infrared Spectroscopy (FTIR) by observing decreases in total helicity and increases in intermolecular beta-sheet formation. Under conditions known to induce changes in the intra-molecular ionic and H-bonding patterns stabilizing the tertiary structure but not affecting the protein's secondary structure or global fold, we have observed upwards of a 12°C shift in the melting temperature of the protein. Furthermore, our results indicated that the T m of unfolding of rhGH was sensitive to much more subtle changes in the protein structure. Thus, resistance to thermal denaturation may well be a useful means to measure structure in formulations of well-characterized therapeutic proteins. Copyright 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.
doi_str_mv 10.1006/biol.2002.0322
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72070878</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1045105602903222</els_id><sourcerecordid>72070878</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-bbebe611caca6df6f4547fb0a5544765dd71ea0dedfd3cbe83a37e549b5cbd9b3</originalsourceid><addsrcrecordid>eNqFkE1LxDAQhoMofl89Sk_eWidp0nS9LeIXrCi4nkM-phjptmuSCvvvbdkFT-JphuF5X5iHkAsKBQWoro3v24IBsAJKxvbIMYWZyOuSwf60c5FTENUROYnxE4BSLvkhOaKMUVlydkxelh8YVrrN3pI2vvVpc5PNs2fUXcxSn81jHAJmSwzJ67AZqTDYNJ18l01RvcYheZu9hj6h7-IZOWh0G_F8N0_J-_3d8vYxX7w8PN3OF7ktJU25MWiwotRqqyvXVA0XXDYGtBCcy0o4JylqcOgaV1qDdalLiYLPjLDGzUx5Sq62vevQfw0Yk1r5aLFtdYf9EJVkIKGW9b8grSsAzmYjWGxBG_oYAzZqHfxqfFpRUJNrNblWk2s1uR4Dl7vmwazQ_eI7uSNQbwEcRXx7DCpaj51F5wPapFzv_-r-AS1sjsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18600429</pqid></control><display><type>article</type><title>Thermal Stability: A Means to Assure Tertiary Structure in Therapeutic Proteins</title><source>ScienceDirect Freedom Collection</source><creator>Cauchy, Mike ; D'aoust, Sophie ; Dawson, Brian ; Rode, Harold ; Hefford, Mary Alice</creator><creatorcontrib>Cauchy, Mike ; D'aoust, Sophie ; Dawson, Brian ; Rode, Harold ; Hefford, Mary Alice</creatorcontrib><description>To be both safe and effective, a therapeutic product must have the correct chemical structure and be free of harmful contaminants. Structure in protein therapeutic products, however, implies not only the correct sequence of amino acids (primary structure) but also the proper folding of that amino acid chain in three-dimensional space (tertiary structure). This work is part of a general strategy to develop a battery of physico-chemical methods that could give assurances of structure (and hence function) in formulated therapeutic proteins in the absence of in vivo data. It focuses on recombinant human growth hormone (rhGH), a well-characterized therapeutic protein, and examines the utility of thermodynamic parameters in assessing its tertiary structure. Resistance of solutions of formulated rhGH to thermal denaturation was followed using Fourier Transform Infrared Spectroscopy (FTIR) by observing decreases in total helicity and increases in intermolecular beta-sheet formation. Under conditions known to induce changes in the intra-molecular ionic and H-bonding patterns stabilizing the tertiary structure but not affecting the protein's secondary structure or global fold, we have observed upwards of a 12°C shift in the melting temperature of the protein. Furthermore, our results indicated that the T m of unfolding of rhGH was sensitive to much more subtle changes in the protein structure. Thus, resistance to thermal denaturation may well be a useful means to measure structure in formulations of well-characterized therapeutic proteins. Copyright 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.</description><identifier>ISSN: 1045-1056</identifier><identifier>EISSN: 1095-8320</identifier><identifier>DOI: 10.1006/biol.2002.0322</identifier><identifier>PMID: 12217342</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Deuterium ; Drug Stability ; Hot Temperature ; Human Growth Hormone - chemistry ; Human Growth Hormone - therapeutic use ; Humans ; Hydrogen ; Hydrogen-Ion Concentration ; In Vitro Techniques ; Protein Denaturation ; Protein Structure, Tertiary ; protein structure, thermal denaturation, stability, therapeutic proteins, quality assurance, FTIR ; Recombinant Proteins - chemistry ; Recombinant Proteins - therapeutic use ; Spectroscopy, Fourier Transform Infrared ; Thermodynamics</subject><ispartof>Biologicals, 2002-09, Vol.30 (3), p.175-185</ispartof><rights>2002 The International Association for Biologicals</rights><rights>Copyright 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-bbebe611caca6df6f4547fb0a5544765dd71ea0dedfd3cbe83a37e549b5cbd9b3</citedby><cites>FETCH-LOGICAL-c371t-bbebe611caca6df6f4547fb0a5544765dd71ea0dedfd3cbe83a37e549b5cbd9b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27900,27901</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12217342$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cauchy, Mike</creatorcontrib><creatorcontrib>D'aoust, Sophie</creatorcontrib><creatorcontrib>Dawson, Brian</creatorcontrib><creatorcontrib>Rode, Harold</creatorcontrib><creatorcontrib>Hefford, Mary Alice</creatorcontrib><title>Thermal Stability: A Means to Assure Tertiary Structure in Therapeutic Proteins</title><title>Biologicals</title><addtitle>Biologicals</addtitle><description>To be both safe and effective, a therapeutic product must have the correct chemical structure and be free of harmful contaminants. Structure in protein therapeutic products, however, implies not only the correct sequence of amino acids (primary structure) but also the proper folding of that amino acid chain in three-dimensional space (tertiary structure). This work is part of a general strategy to develop a battery of physico-chemical methods that could give assurances of structure (and hence function) in formulated therapeutic proteins in the absence of in vivo data. It focuses on recombinant human growth hormone (rhGH), a well-characterized therapeutic protein, and examines the utility of thermodynamic parameters in assessing its tertiary structure. Resistance of solutions of formulated rhGH to thermal denaturation was followed using Fourier Transform Infrared Spectroscopy (FTIR) by observing decreases in total helicity and increases in intermolecular beta-sheet formation. Under conditions known to induce changes in the intra-molecular ionic and H-bonding patterns stabilizing the tertiary structure but not affecting the protein's secondary structure or global fold, we have observed upwards of a 12°C shift in the melting temperature of the protein. Furthermore, our results indicated that the T m of unfolding of rhGH was sensitive to much more subtle changes in the protein structure. Thus, resistance to thermal denaturation may well be a useful means to measure structure in formulations of well-characterized therapeutic proteins. Copyright 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.</description><subject>Deuterium</subject><subject>Drug Stability</subject><subject>Hot Temperature</subject><subject>Human Growth Hormone - chemistry</subject><subject>Human Growth Hormone - therapeutic use</subject><subject>Humans</subject><subject>Hydrogen</subject><subject>Hydrogen-Ion Concentration</subject><subject>In Vitro Techniques</subject><subject>Protein Denaturation</subject><subject>Protein Structure, Tertiary</subject><subject>protein structure, thermal denaturation, stability, therapeutic proteins, quality assurance, FTIR</subject><subject>Recombinant Proteins - chemistry</subject><subject>Recombinant Proteins - therapeutic use</subject><subject>Spectroscopy, Fourier Transform Infrared</subject><subject>Thermodynamics</subject><issn>1045-1056</issn><issn>1095-8320</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqFkE1LxDAQhoMofl89Sk_eWidp0nS9LeIXrCi4nkM-phjptmuSCvvvbdkFT-JphuF5X5iHkAsKBQWoro3v24IBsAJKxvbIMYWZyOuSwf60c5FTENUROYnxE4BSLvkhOaKMUVlydkxelh8YVrrN3pI2vvVpc5PNs2fUXcxSn81jHAJmSwzJ67AZqTDYNJ18l01RvcYheZu9hj6h7-IZOWh0G_F8N0_J-_3d8vYxX7w8PN3OF7ktJU25MWiwotRqqyvXVA0XXDYGtBCcy0o4JylqcOgaV1qDdalLiYLPjLDGzUx5Sq62vevQfw0Yk1r5aLFtdYf9EJVkIKGW9b8grSsAzmYjWGxBG_oYAzZqHfxqfFpRUJNrNblWk2s1uR4Dl7vmwazQ_eI7uSNQbwEcRXx7DCpaj51F5wPapFzv_-r-AS1sjsg</recordid><startdate>20020901</startdate><enddate>20020901</enddate><creator>Cauchy, Mike</creator><creator>D'aoust, Sophie</creator><creator>Dawson, Brian</creator><creator>Rode, Harold</creator><creator>Hefford, Mary Alice</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20020901</creationdate><title>Thermal Stability: A Means to Assure Tertiary Structure in Therapeutic Proteins</title><author>Cauchy, Mike ; D'aoust, Sophie ; Dawson, Brian ; Rode, Harold ; Hefford, Mary Alice</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-bbebe611caca6df6f4547fb0a5544765dd71ea0dedfd3cbe83a37e549b5cbd9b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Deuterium</topic><topic>Drug Stability</topic><topic>Hot Temperature</topic><topic>Human Growth Hormone - chemistry</topic><topic>Human Growth Hormone - therapeutic use</topic><topic>Humans</topic><topic>Hydrogen</topic><topic>Hydrogen-Ion Concentration</topic><topic>In Vitro Techniques</topic><topic>Protein Denaturation</topic><topic>Protein Structure, Tertiary</topic><topic>protein structure, thermal denaturation, stability, therapeutic proteins, quality assurance, FTIR</topic><topic>Recombinant Proteins - chemistry</topic><topic>Recombinant Proteins - therapeutic use</topic><topic>Spectroscopy, Fourier Transform Infrared</topic><topic>Thermodynamics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cauchy, Mike</creatorcontrib><creatorcontrib>D'aoust, Sophie</creatorcontrib><creatorcontrib>Dawson, Brian</creatorcontrib><creatorcontrib>Rode, Harold</creatorcontrib><creatorcontrib>Hefford, Mary Alice</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biologicals</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cauchy, Mike</au><au>D'aoust, Sophie</au><au>Dawson, Brian</au><au>Rode, Harold</au><au>Hefford, Mary Alice</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thermal Stability: A Means to Assure Tertiary Structure in Therapeutic Proteins</atitle><jtitle>Biologicals</jtitle><addtitle>Biologicals</addtitle><date>2002-09-01</date><risdate>2002</risdate><volume>30</volume><issue>3</issue><spage>175</spage><epage>185</epage><pages>175-185</pages><issn>1045-1056</issn><eissn>1095-8320</eissn><abstract>To be both safe and effective, a therapeutic product must have the correct chemical structure and be free of harmful contaminants. Structure in protein therapeutic products, however, implies not only the correct sequence of amino acids (primary structure) but also the proper folding of that amino acid chain in three-dimensional space (tertiary structure). This work is part of a general strategy to develop a battery of physico-chemical methods that could give assurances of structure (and hence function) in formulated therapeutic proteins in the absence of in vivo data. It focuses on recombinant human growth hormone (rhGH), a well-characterized therapeutic protein, and examines the utility of thermodynamic parameters in assessing its tertiary structure. Resistance of solutions of formulated rhGH to thermal denaturation was followed using Fourier Transform Infrared Spectroscopy (FTIR) by observing decreases in total helicity and increases in intermolecular beta-sheet formation. Under conditions known to induce changes in the intra-molecular ionic and H-bonding patterns stabilizing the tertiary structure but not affecting the protein's secondary structure or global fold, we have observed upwards of a 12°C shift in the melting temperature of the protein. Furthermore, our results indicated that the T m of unfolding of rhGH was sensitive to much more subtle changes in the protein structure. Thus, resistance to thermal denaturation may well be a useful means to measure structure in formulations of well-characterized therapeutic proteins. Copyright 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>12217342</pmid><doi>10.1006/biol.2002.0322</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1045-1056
ispartof Biologicals, 2002-09, Vol.30 (3), p.175-185
issn 1045-1056
1095-8320
language eng
recordid cdi_proquest_miscellaneous_72070878
source ScienceDirect Freedom Collection
subjects Deuterium
Drug Stability
Hot Temperature
Human Growth Hormone - chemistry
Human Growth Hormone - therapeutic use
Humans
Hydrogen
Hydrogen-Ion Concentration
In Vitro Techniques
Protein Denaturation
Protein Structure, Tertiary
protein structure, thermal denaturation, stability, therapeutic proteins, quality assurance, FTIR
Recombinant Proteins - chemistry
Recombinant Proteins - therapeutic use
Spectroscopy, Fourier Transform Infrared
Thermodynamics
title Thermal Stability: A Means to Assure Tertiary Structure in Therapeutic Proteins
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-25T12%3A18%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thermal%20Stability:%20A%20Means%20to%20Assure%20Tertiary%20Structure%20in%20Therapeutic%20Proteins&rft.jtitle=Biologicals&rft.au=Cauchy,%20Mike&rft.date=2002-09-01&rft.volume=30&rft.issue=3&rft.spage=175&rft.epage=185&rft.pages=175-185&rft.issn=1045-1056&rft.eissn=1095-8320&rft_id=info:doi/10.1006/biol.2002.0322&rft_dat=%3Cproquest_cross%3E72070878%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c371t-bbebe611caca6df6f4547fb0a5544765dd71ea0dedfd3cbe83a37e549b5cbd9b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18600429&rft_id=info:pmid/12217342&rfr_iscdi=true